Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation.
Lefaucheur, Carmen; Loupy, Alexandre; Hill, Gary S; Andrade, Joao; Nochy, Dominique; Antoine, Corinne; Gautreau, Chantal; Charron, Dominique; Glotz, Denis; Suberbielle-Boissel, Caroline.
J Am Soc Nephrol
; 21(8): 1398-406, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20634297
Application, technical issues, and interpretation of C1q for graft outcome.
HLA antibody profiling in thoracic transplantation undergoing desensitization therapy.
The detection and role of circulating antibodies in rejection.
Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss.
The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation.
Molecular diagnostics in renal allograft biopsy interpretation: potential and pitfalls.
The impact of antibodies and virtual crossmatching on intestinal transplant outcomes.
Donor-specific HLA antibody-mediated complement activation is a significant indicator of antibody-mediated rejection and poor long-term graft outcome during lung transplantation: a single center cohort study.
Donor-specific antibodies and antibody-mediated rejection in vascularized composite allotransplantation.